[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585908":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":56,"collaborators":25,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":25,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":25,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":77,"overallStatus":42,"whyStopped":25,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University of Sydney","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Cognitive Bias Modification for Interpretation","EXPERIMENTAL","The Ambiguous Scenarios paradigm is administered remotely online. The intervention is administered four times: at day 1, day 4, day 7, and day 14. Each intervention presents 30 ambiguous scenarios and associated comprehension questions, and should take approximately 20 minutes to complete. All scenarios in this arm are resolved to be benign.",[13],"Behavioral: Cognitive Bias Modification for Interpretation",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo Cognitive Bias Modification for Interpretation","PLACEBO_COMPARATOR","The placebo Ambiguous Scenarios paradigm is administered remotely online. The intervention is administered four times: at day 1, day 4, day 7, and day 14. Each intervention presents 30 ambiguous scenarios and associated comprehension questions, and should take approximately 20 minutes to complete. Scenarios are resolved as either benign or pain-related, with equal numbers (15) of each per session.",[19],"Behavioral: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Cognitive Bias Modification involves administering the Ambiguous Scenarios paradigm. This is a series of ambiguous scenarios which could be resolved to be associated with pain. The task consists of 30 unique scenarios and an associated comprehension question (pertaining to the pain-relatedness of the scenario), which are presented in a random order to participants.\n\nEach scenario presents an ambiguous sentence, ending with a word fragment which the participant must complete. The statement remains ambiguous until the completion of the word fragment, which resolves the statement as either pain-related or benign. For example, the statement \"You are bush walking. Suddenly, you trip over and fall onto your knees. Your knees feel all wet, and you look down to see...\" can be followed by \"le\\_v\\_s \\[leaves\\]\" for a benign resolution, or \"bl\\_\\_d \\[blood\\]\" for a pain-related resolution. In the intervention group, all 30 scenarios will be followed with the benign word fragment.",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo","The Ambiguous Scenarios paradigm described previously will be used for the placebo intervention. The same 30 scenarios will be presented to participants, however 50% (15) trials will be followed by the benign word fragment, ad 50% (15) trials will be followed by the pain-related word fragment.",[15],[31],{"name":32,"affiliation":5,"role":33},"Louise Sharpe","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Tessa Rooney","CONTACT","+61449610131","tessa.rooney@sydney.edu.au",[41],{"facility":5,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Camperdown","New South Wales","2006","Australia","AU",{"type":49,"coordinates":50},"Point",[51,52],151.17642,-33.88965,{"lat":52,"lon":51},[55],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},{"type":57,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100585908","cognitive-bias-modification-for-interpretation-cbm-i-in-people-with-type-2-diabetes-and-persistent-pain-100585908",false,"NCT06908486","Cognitive Bias Modification for Interpretation (CBM-I) in People With Type 2 Diabetes and Persistent Pain","Assessing Cognitive Bias Modification for Interpretation (CBM-I) on Pain Severity and Interference in People With Type 2 Diabetes and Persistent Pain","Inclusion Criteria:\n\n* Over 18 years of age\n* Have a diagnosis of Type 2 diabetes.\n* Have persistent pain (pain present on more days than not, for 3 months or longer).\n* Score ≥ 3 on average pain severity on the Brief Pain Inventory (BPI).\n* Fluent in English\n* Have access to internet and ability to use a computer over a three month period.\n\nExclusion Criteria:\n\n* Under 18 years of age\n* No diagnosis of Type 2 diabetes\n* No persistent pain\n* Not fluent in English\n* No access to internet nor ability to use a computer.","ALL","18 Years",{"count":68,"type":69},319,"ESTIMATED","INTERVENTIONAL",[72],"NA","The goal of this clinical trial is to examine the efficacy of cognitive bias modification for interpretation (CBM-I) in people with Type 2 Diabetes and persistent pain. The main question\\[s\\] it aims to answer is whether interpretation bias training away from pain improves pain outcomes.\n\nParticipants in the CBM-I group will complete 4 online training sessions approximately half an hour each. Each session will present participants with ambiguous scenarios which may be pain-related, however the final word of the sentence will resolve the scenario as benign (thus training participants to make benign interpretations). A measure of interpretation bias will be administered following the fourth training session, and pain severity and interference will be measured at baseline, post-training, two week follow up, and three month follow up.\n\nThe study hypothesises that participants in the CBM-I group will demonstrate a greater reduction in the co-primary outcomes of pain severity and pain interference over time compared to those in the placebo control.",[75,76],"Type 2 Diabetes","Persistent Pain",[78,79,80,81],"cognitive bias modification","interpretation bias","type 2 diabetes","pain","2025-05-27",{"date":84,"type":85},"2025-06-02","ACTUAL",{"date":87,"type":85},"2025-04-15",{"date":89,"type":69},"2025-10-15",{"name":5,"class":6},1]